Back
Marinus Pharmaceuticals Stock Price Chart
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Buy
63
MRNS
Marinus Pharmaceuticals
Last Price:
$0.54
Seasonality Move:
1.39%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing slight buying pressure.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.38 | Buy |
| 50-day SMA: | 0.34 | Buy |
| 200-day SMA: | 1.64 | Sell |
| 8-day EMA: | 0.5 | Buy |
| 20-day EMA: | 0.43 | Buy |
| 50-day EMA: | 0.52 | Buy |
| 200-day EMA: | 2.12 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 70.74 | Buy |
| Chaikin Money Flow: | -216238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.24 - 0.48) | Buy |
| Bollinger Bands (100): | (0.28 - 1.56) | Sell |
Marinus Pharmaceuticals Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
-
Marinus Pharmaceuticals share price is 0.54 while MRNS 8-day simple moving average is 0.53, which is a Buy signal.
-
The stock price of MRNS is 0.54 while Marinus Pharmaceuticals 20-day SMA is 0.38, which makes it a Buy.
-
Marinus Pharmaceuticals 50-day simple moving average is 0.34 while MRNS share price is 0.54, making it a Buy technically.
-
MRNS stock price is 0.54 and Marinus Pharmaceuticals 200-day simple moving average is 1.64, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Buy
63
Marinus Pharmaceuticals (MRNS)
is a Buy
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a BuyThe current Marinus Pharmaceuticals [MRNS] share price is $0.54. The Score for MRNS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
29.7M
Price in USD:
0.54
Share Volume:
2.4M
Marinus Pharmaceuticals 52-Week Range
52-Week High:
10.50
52-Week Low:
0.22
Buy
63
Marinus Pharmaceuticals (MRNS)
is a Buy
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?The Marinus Pharmaceuticals stock price is 0.54 USD today.
-
Will MRNS stock go up or go down?Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Marinus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is not overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
-
Marinus Pharmaceuticals share price is 0.54 while MRNS 8-day exponential moving average is 0.50, which is a Buy signal.
-
The stock price of MRNS is 0.54 while Marinus Pharmaceuticals 20-day EMA is 0.43, which makes it a Buy.
-
Marinus Pharmaceuticals 50-day exponential moving average is 0.52 while MRNS share price is 0.54, making it a Buy technically.
-
MRNS stock price is 0.54 and Marinus Pharmaceuticals 200-day simple moving average is 2.12, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $0.28 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
-
MRNS Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Marinus Pharmaceuticals is a Buy
-
Marinus Pharmaceuticals Relative Strength Index (RSI) is 70.74, which suggest Marinus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Marinus Pharmaceuticals is (0.24 - 0.48), which suggest Marinus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Marinus Pharmaceuticals is (0.28 - 1.56), which suggest Marinus Pharmaceuticals is a Sell
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.